Work

874P Preliminary outcomes from a phase Ib/II study of WX390 combined with toripalimab in patients with recurrent or metastatic head and neck squamous cell carcinoma

Year: 2024

Type: article

Study design: Clinical Trial

Source: Annals of Oncology

DOI: 10.1016/j.annonc.2024.08.935

Authors: Y. Guo, L. Xue, W. Tang, B. Li, Z. zhu, Y. Ding, L. Niu, Y. Jia, X. Jia, Y. Qi, Y. Li

Institutions: Tongji University, Shanghai East Hospital, Guilin Medical University, First Hospital of Jilin University, Second People’s Hospital of Yibin

Language: English

Topic: Cancer Immunotherapy and Biomarkers

Subfield: Oncology

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: bronze

OpenAlex ID: W4402560813

FWCI:

Cites:

Cited by:

Related to: 10